These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 30227430

  • 1. Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy.
    Yamamoto A, Toiyama Y, Okugawa Y, Saigusa S, Ide S, Fujikawa H, Hiro J, Yasuda H, Yoshiyama S, Ohi M, Araki T, Kusunoki M.
    Oncology; 2019; 96(2):70-78. PubMed ID: 30227430
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.
    Nakagawa R, Inoue Y, Ohki T, Kaneko Y, Maeda F, Yamamoto M.
    World J Surg Oncol; 2017 May 31; 15(1):112. PubMed ID: 28566093
    [Abstract] [Full Text] [Related]

  • 3. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li T, Cooper H, Konski A, Farma JM, Sigurdson ER.
    Ann Surg Oncol; 2012 Jul 31; 19(7):2178-85. PubMed ID: 22395978
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of pathological response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Tomono A, Yamashita K, Kanemitsu K, Sumi Y, Yamamoto M, Kanaji S, Imanishi T, Nakamura T, Suzuki S, Tanaka K, Kakeji Y.
    Int J Clin Oncol; 2016 Apr 31; 21(2):344-349. PubMed ID: 26338272
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.
    Li Q, Luo D, Zhu J, Yang L, Liu Q, Ma Y, Liang L, Cai S, Zhang Z, Li X, ACRNaCT study group.
    BMC Cancer; 2019 Nov 15; 19(1):1117. PubMed ID: 31729964
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preoperative chemoradiotherapy with oxaliplatin and tegafur-uracil in locally advanced rectal cancer: pathologic complete response rate and preliminary results of overall and disease-free survival in a single institute in Taiwan.
    Chao JY, Wang HM, Chiang FF, Lin JC, Chang CF, Lin JF, Yeh HL.
    J Chin Med Assoc; 2014 Mar 15; 77(3):128-32. PubMed ID: 24398439
    [Abstract] [Full Text] [Related]

  • 12. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
    Tural D, Ozturk M, Selcukbiricik F, Yildiz O, Elicin O, Turna H, Guney S, Ozguroglu M.
    J BUON; 2013 Mar 15; 18(2):385-90. PubMed ID: 23818350
    [Abstract] [Full Text] [Related]

  • 13. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
    Markovina S, Youssef F, Roy A, Aggarwal S, Khwaja S, DeWees T, Tan B, Hunt S, Myerson RJ, Chang DT, Parikh PJ, Olsen JR.
    Int J Radiat Oncol Biol Phys; 2017 Oct 01; 99(2):417-426. PubMed ID: 28871992
    [Abstract] [Full Text] [Related]

  • 14. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS, Nam BH, Kim KP, Kim JE, Park SJ, Park YS, Park JO, Kim SY, Kim TY, Kim JH, Ahn JB, Lim SB, Yu CS, Kim JC, Yun SH, Kim JH, Park JH, Park HC, Jung KH, Kim TW.
    Lancet Oncol; 2014 Oct 01; 15(11):1245-53. PubMed ID: 25201358
    [Abstract] [Full Text] [Related]

  • 15. Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.
    Sclafani F, Brown G, Cunningham D, Rao S, Tekkis P, Tait D, Morano F, Baratelli C, Kalaitzaki E, Rasheed S, Watkins D, Starling N, Wotherspoon A, Chau I.
    Oncologist; 2017 Jun 01; 22(6):728-736. PubMed ID: 28476941
    [Abstract] [Full Text] [Related]

  • 16. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T, Ueno M, Matsueda K, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y, Unno T, Kano A, Kuroyanagi H, Oya M, Yamaguchi T, Watanabe T, Muto T.
    Ann Surg Oncol; 2014 Jan 01; 21(1):189-96. PubMed ID: 23963871
    [Abstract] [Full Text] [Related]

  • 17. Gene expression levels of gamma-glutamyl hydrolase in tumor tissues may be a useful biomarker for the proper use of S-1 and tegafur-uracil/leucovorin in preoperative chemoradiotherapy for patients with rectal cancer.
    Sadahiro S, Suzuki T, Tanaka A, Okada K, Saito G, Miyakita H, Ogimi T, Nagase H.
    Cancer Chemother Pharmacol; 2017 Jun 01; 79(6):1077-1085. PubMed ID: 28417167
    [Abstract] [Full Text] [Related]

  • 18. Number of Lymph Nodes in Rectal Cancer is Correlated with Response to Preoperative Chemoradiotherapy but is not Associated with Patient Survival.
    Ishihara S, Fukushima Y, Akahane T, Horiuchi A, Shimada R, Nakamura K, Aoyagi Y, Hayama T, Yamada H, Nozawa K, Matsuda K, Hashiguchi Y, Watanabe T.
    Hepatogastroenterology; 2014 Jun 01; 61(132):1000-7. PubMed ID: 26158156
    [Abstract] [Full Text] [Related]

  • 19. [A case of long-term survival after resection of advanced undifferentiated rectal cancer treated by short-term preoperative chemoradiotherapy and postoperative adjuvant chemotherapy].
    Naito Y, Hashiguchi Y, Ueno H, Kajiwara Y, Shimazaki H, Mochizuki H, Hase K.
    Gan To Kagaku Ryoho; 2011 Jan 01; 38(1):117-20. PubMed ID: 21368471
    [Abstract] [Full Text] [Related]

  • 20. Impact of perineural and lymphovascular invasion on oncological outcomes in rectal cancer treated with neoadjuvant chemoradiotherapy and surgery.
    Cienfuegos JA, Rotellar F, Baixauli J, Beorlegui C, Sola JJ, Arbea L, Pastor C, Arredondo J, Hernández-Lizoáin JL.
    Ann Surg Oncol; 2015 Mar 01; 22(3):916-23. PubMed ID: 25190129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.